>
|
 |
츮 Ͻ ˵ ԡ
|
|
|
|
索 ȯ , Ը CAPA Ȯ
|
|
|
|
|
|
|
۸ ڣ
ȸ簡 索 ȯ , Ը CAPA Ȯ ˵ ̶ Դ.
5 츮ǿ 2013 Ը 428( 11.9% ) Ǹ Ը 148(+14.2%) ߿ 34.7% Ѵ.
WHO ϸ 2030 索 ȯ 36610 2000 17120 113.8% ȴ. αȭ, ı Ȯ, Ȱ ȭ, ҵ 索 ȯ δ.
ű 5 캸 Roche M/S 33%, Johnson&Johnson 27%, Bayer 15%, Abbott 14%, Arkray 5% M/S 94% Ѵ.
̼ 罺Ʈ ȸ ǰ 罺Ʈ 82.7%, 5.6%, 4.2%, Ÿ 7.5%̸ ̱ 45.7%, ѱ 20.3%, ƽþ 15.1%, 11.6%, Ÿ 7.3% Ѵ.
CAPA ְ 5ﰳ, ۵ 2ﰳ ջδ 7ﰳ شȴ. 2014 CAPA ǥ 14ﰳ ۵ 2ﰳ , 2 5ﰳ ȹ ִٰ.
2006 ̱ AgaMatrix 罺Ʈ ü AgaMatrix 2010 8 ٱ ȸ縦 罺Ʈ ߴ. 2011 Ϻ Arkray 罺Ʈ üߴ.
2012 9 2015 8 θ 罺Ʈ ü 2012 50 ߰ 2013~2015 80~100 ȴ. 2013 ۵ ȭǸ 强 ͼ ̴. 2013 850( +27.7%), 150(+89%), 130(+48.6%) ȴ.
ƿ 1б 190(+46.4%), 34(+94.1%) Ǹ Ư 2012 42.8% ̴.
(acepark@mdtoday.co.kr)
<ǰ ̴ ѹα ǥ Ƿ, ǰ Ź , >
|
|
|
|